John Duan

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

Martin H. Cohen, Grant Williams, John R. Johnson et al. · PubMed · 2002 · 469 citations

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

John R. Johnson, Martin H. Cohen, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2005 · 212 citations · Full text

Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary

Katherine A. Thornton, Geoffrey Kim, V. Ellen Maher et al. · Clinical Cancer Research · 2012 · 147 citations

Caprelsa Tablets, U.s. Food, Medicine +11

Impact of Pharmacometric Reviews on New Drug Approval and Labeling Decisions—a Survey of 31 New Drug Applications Submitted Between 2005 and 2006

Venkatesh Atul Bhattaram, Charles R. Bonapace, Dakshina Chilukuri et al. · Clinical Pharmacology & Therapeutics · 2007 · 118 citations

Drug Safety, Drug Interactions, Labeling Decisions—a Survey +15

Regulatory Experience with In Vivo In Vitro Correlations (IVIVC) in New Drug Applications

Sandra Suarez‐Sharp, Min Li, John Duan et al. · The AAPS Journal · 2016 · 95 citations

Vitro Correlations, Signal Transduction, Preclinical Drug Evaluation +8